Notice NOT-OD-24-120 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-115 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-113 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-24-202 from the NIH Guide for Grants and Contracts. This FOA encourages applications for the Lasker Clinical Research Scholars Program for the purpose of supporting the research activities during the early stage careers of independent clinical researchers. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research facility; or, the Scholar can be considered to remain as an investigator within the intramural program.

Notice NOT-TR-24-024 from the NIH Guide for Grants and Contracts

Notice NOT-CA-24-048 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-109 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-261 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-265 from the NIH Guide for Grants and Contracts

Notice NOT-MH-24-260 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-096 from the NIH Guide for Grants and Contracts

Notice NOT-EY-24-005 from the NIH Guide for Grants and Contracts

Notice NOT-HG-24-032 from the NIH Guide for Grants and Contracts

Notice NOT-DA-25-030 from the NIH Guide for Grants and Contracts

Notice NOT-OD-24-110 from the NIH Guide for Grants and Contracts

Notice NOT-HG-24-034 from the NIH Guide for Grants and Contracts

Notice NOT-HG-24-033 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-MH-25-185 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R01 grant mechanism, while RFA-MH-25-186 uses the R21 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

Funding Opportunity RFA-MH-25-186 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to solicit research designed to capacitate, transform, and scale the delivery of HIV testing, prevention, and care services through pharmacists and pharmacies in US and/or global settings. This includes theadvancement of training curricula to enable pharmacy students, pharmacists, pharmacies, and pharmacy systems to deliver the spectrum of needed HIV services with ease, equity, and effectiveness. This NOFO uses the R21 grant mechanism, while RFA-MH-25-185 uses the R01 mechanism. Projects that lack preliminary data or that propose to pilot a novel intervention may be most appropriate for the R21 mechanism. Applications with preliminary data and those proposing large-scale clinical trials or longitudinal analyses should consider using the R01 mechanism.

Notice NOT-TW-24-005 from the NIH Guide for Grants and Contracts